Health & Environmental Research Online (HERO)


Print Feedback Export to File
1543217 
Journal Article 
Review 
Recent advances in the study on resveratrol 
Nakata, R; Takahashi, S; Inoue, H 
2012 
Yes 
Biological and Pharmaceutical Bulletin
ISSN: 0918-6158
EISSN: 1347-5215 
35 
3 
273-279 
English 
22382311 
WOS:000300925200001 
Appropriate long-term drinking of red wine is associated with a reduced risk for lifestyle-related diseases such as cardiovascular disease and cancer, making resveratrol, a constituent of grapes and various other plants, an attractive compound to be studied. Historically, resveratrol has been identified as a phytoalexin, antioxidant, cyclooxygenase (COX) inhibitor, peroxisome proliferator-activated receptor (PPAR) activator, endothelial nitric oxide synthase (eNOS) inducer, silent mating type information regulation 2 homolog 1 (SIRT1) activator, and more. Despite scepticism concerning the biological availability of resveratrol, a growing body of in vivo evidence indicates that resveratrol has protective effects in several stress and disease models. Here, we provide a review of the studies on resveratrol, especially with respect to COX, PPAR, and eNOS activities, and discuss its potential for promoting human health. 
resveratrol; cyclooxygenase; peroxisome proliferator-activated receptor; endothelial nitric oxide synthase; silent mating type information regulation 2 homolog 1